Explain this page
Arphra AIPlain-English read on Pulse Biosciences, Inc.’s valuationBusiness description
· company · SEC profilePulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Founded
—
IPO
May 18, 2016
Employees
75
HQ
Miami, CA
CEO
Paul Arthur LaViolette
CFO
—
Exchange
NASDAQ
Fiscal year
—
Identifiers
· company_identifiersCIK0001625101
CUSIP74587B101
ISINUS74587B1017
FIGIPLSE US
LEI—